elvitegravir

FDA rejects two Gilead HIV drugs as standalone products

FDA rejects two Gilead HIV drugs as standalone products

Reuters

Gilead HIV drug as good as Merck's Isentress: study

Gilead HIV drug as good as Merck's Isentress: study

Reuters

Gilead Reports Non-inferior Data From Phase 3 Study Of Elvitegravir In HIV

Gilead Reports Non-inferior Data From Phase 3 Study Of Elvitegravir In HIV

NASDAQ.com

It's the Combo That Matters for Gilead

It's the Combo That Matters for Gilead

Motley Fool

News

GILD's Elvitegravir Meets Study Goal

Yahoo/Zacks

News

Gilead HIV drug meets study goal

Yahoo/AP